I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
8-Methoxypsoralen, is used in Photochemotherapy (methoxsalen with long wave ultraviolet radiation) is indicated for the repigmentation of idiopathic vitiligo. It is also used in Photopheresis (methoxsalen with long wave ultraviolet radiation of white blood cells) is indicated for use with the UVAR* System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma.
NJ Lowe.; D Weingarten.; T Bourget, LS Moy. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. Journal of the American Academy of Dermatology. 198614 (5), 754-760.
S Igali.; BA Bridges.; MJ Ashwood-Smith. Mutagenesis in Escherichia coli IV. Photosensitization to near ultraviolet light by 8-methoxypsoralen. Journal of the American Academy of Dermatology. 19709 (1), 21-30.
Hazard Statements: H302-H317-H350
Harmful if swallowed. May cause an allergic skin reaction. May cause cancer.
Precautionary Statements: P201-P261-P280-P301+P312a-P405-P501a
Obtain special instructions before use. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.